Garima Arora

510 total citations
11 papers, 343 citations indexed

About

Garima Arora is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Garima Arora has authored 11 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Garima Arora's work include Tuberculosis Research and Epidemiology (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Garima Arora is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Garima Arora collaborates with scholars based in India, United States and South Korea. Garima Arora's co-authors include Ramandeep Singh, Saqib Kidwai, Prabhakar Tiwari, Mamta Singh, Om Narayan, Santosh Kumar, Deepak Sharma, Sakshi Agarwal, Rahul Shubhra Mandal and Sudipto Saha and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Scientific Reports.

In The Last Decade

Garima Arora

11 papers receiving 339 citations

Peers

Garima Arora
Eileen Pagán-Ramos United States
Srijon K. Banerjee United States
Andrew Avarbock United States
Cuixiang Meng United Kingdom
Claire Healy Ireland
Ashley M. Sherrid United States
Monika Jankute United Kingdom
Garima Arora
Citations per year, relative to Garima Arora Garima Arora (= 1×) peers Magnus Steigedal

Countries citing papers authored by Garima Arora

Since Specialization
Citations

This map shows the geographic impact of Garima Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garima Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garima Arora more than expected).

Fields of papers citing papers by Garima Arora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garima Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garima Arora. The network helps show where Garima Arora may publish in the future.

Co-authorship network of co-authors of Garima Arora

This figure shows the co-authorship network connecting the top 25 collaborators of Garima Arora. A scholar is included among the top collaborators of Garima Arora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garima Arora. Garima Arora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Singh, Dhiraj Kumar, Mushtaq Ahmed, Sadia Akter, et al.. (2025). Prevention of tuberculosis in cynomolgus macaques by an attenuated Mycobacterium tuberculosis vaccine candidate. Nature Communications. 16(1). 1957–1957. 1 indexed citations
2.
Singh, Bindu, Riti Sharan, Gayathri Ravichandran, et al.. (2024). Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection. JCI Insight. 9(15). 2 indexed citations
3.
Singh, Bindu, Chivonne Moodley, Dhiraj Kumar Singh, et al.. (2023). Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy. JCI Insight. 8(2). 16 indexed citations
4.
Tiwari, Prabhakar, Mamta Singh, Garima Arora, et al.. (2022). Exopolyphosphatases PPX1 and PPX2 from Mycobacterium tuberculosis regulate dormancy response and pathogenesis. Microbial Pathogenesis. 173(Pt B). 105885–105885. 4 indexed citations
5.
Arora, Garima, Assirbad Behura, Saqib Kidwai, et al.. (2020). NSC 18725, a Pyrazole Derivative Inhibits Growth of Intracellular Mycobacterium tuberculosis by Induction of Autophagy. Frontiers in Microbiology. 10. 3051–3051. 24 indexed citations
6.
Arora, Garima, Deepika Chaudhary, Saqib Kidwai, Deepak Sharma, & Ramandeep Singh. (2018). CitE Enzymes Are Essential for Mycobacterium tuberculosis to Establish Infection in Macrophages and Guinea Pigs. Frontiers in Cellular and Infection Microbiology. 8. 385–385. 22 indexed citations
7.
Singh, Mamta, Prabhakar Tiwari, Garima Arora, et al.. (2016). Establishing Virulence Associated Polyphosphate Kinase 2 as a drug target for Mycobacterium tuberculosis. Scientific Reports. 6(1). 26900–26900. 40 indexed citations
8.
Tiwari, Prabhakar, Garima Arora, Mamta Singh, et al.. (2015). MazF ribonucleases promote Mycobacterium tuberculosis drug tolerance and virulence in guinea pigs. Nature Communications. 6(1). 6059–6059. 116 indexed citations
9.
Park, Chan-Yong, et al.. (2015). Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs. Bioorganic & Medicinal Chemistry Letters. 25(17). 3650–3653. 13 indexed citations
10.
Arora, Garima, et al.. (2014). High Throughput Screen Identifies Small Molecule Inhibitors Specific for Mycobacterium tuberculosis Phosphoserine Phosphatase. Journal of Biological Chemistry. 289(36). 25149–25165. 31 indexed citations
11.
Singh, Ramandeep, Mamta Singh, Garima Arora, et al.. (2013). Polyphosphate Deficiency in Mycobacterium tuberculosis Is Associated with Enhanced Drug Susceptibility and Impaired Growth in Guinea Pigs. Journal of Bacteriology. 195(12). 2839–2851. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026